Ambrx Biopharma, Inc.
CIK 0001990550
Revenue (TTM)
—
Q3 Nov 2023
Net Income (TTM)
—
Q3 Nov 2023
EPS Diluted (TTM)
—
Q3 Nov 2023
Gross Margin
—
Q3 Nov 2023
Operating Margin
—
Q3 Nov 2023
Net Margin
—
Q3 Nov 2023
Free Cash Flow (TTM)
—
Q3 Nov 2023
Cash
$225.26M
Q3 Nov 2023
Total Debt
—
Q3 Nov 2023
Shares Outstanding
63.15M sh
Q3 Nov 2023